Results 1 to 10 of about 9,261,498 (243)
Journal of Education, Health and Sport, 2023 Background: Graves' disease is responsible for 60-80% causes of hyperthyreosis. An important role in the pathogenesis is played by anti-TSHR immunoglobulins (TRAb), that stimulate TSH receptors leading to excessive hormone synthesis and release by the ...
Natalia Woś +9 more
doaj +1 more source
Graves’ disease: moving forwards
Archives of Disease in Childhood, 2022 Graves’ disease is a rare disorder that continues to present clinicians and families with a series of challenges. There are no new established treatments for children or adolescents, but the outcomes of recent clinical trials and meta-analyses have ...
L. Lane, Claire L Wood, T. Cheetham
semanticscholar +1 more source
The Occurrence of a Thyroid Storm in a Patient with Recurrent Refractory Peptic Ulcer: A Case Report [PDF]
Journal of Acute Care Surgery, 2022 A thyroid storm is a rare complication of hyperthyroidism. Although a thyroid storm rarely presents with symptoms similar to those of an acute abdomen, and in cases where emergency surgery is needed, the thyroid function test is not performed routinely ...
Kwanhoon Park, Ji Young Jang, Sungho Lee
doaj +1 more source
Long-term management of Graves disease: a narrative review [PDF]
Journal of Yeungnam Medical Science, 2023 Graves disease (GD) is the most common cause of hyperthyroidism, accounting for more than 90% of cases in Korea. Patients with GD are treated with any of the following: antithyroid drugs (ATDs), radioactive iodine (RAI) therapy, or thyroidectomy.
Hyo-Jeong Kim
doaj +1 more source
Radioactive iodine in the treatment of Graves' disease: history and modern concept of radionuclide therapy [PDF]
Терапевтический архив, 2022 Radioactive iodine 131I is a theranostic isotope used both for diagnosis and therapy of benign thyroid diseases and thyroid cancer for 85 years. The formation of nuclear medicine is closely linked with the use of 131I.
Marina S. Sheremeta +3 more
doaj +1 more source
Two further cases of Graves’ disease following SARS-Cov-2 vaccination
Journal of Endocrinological Investigation, 2021 Recently, two cases of Graves’ disease after SARS-Cov2 RNA vaccination with tozinameran have been reported [1]. Here, we report two further cases: a late recurrence after 17 years and an initial manifestation. A 71-year-old lady had subtotal resection of
G. Zettinig, M. Krebs
semanticscholar +1 more source
The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy, 2022 Graves' disease is an autoimmune thyroid disease with several characteristic symptoms and signs. Graves' ophthalmopathy, an inflammatory disease in the orbital area, is the main extrathyroid manifestation of Graves' disease.
Herry Krisnata Ginting, Soebagijo Adi
doaj +1 more source
SARS-CoV-2 plays a pivotal role in inducing hyperthyroidism of Graves’ disease
Endocrine, 2021 Coronavirus disease 2019 (COVID-19) advances to affect every part of the globe and remains a challenge to the human race. Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) was shown to affect many organs and organ systems including the thyroid
A. K. Murugan, A. Alzahrani
semanticscholar +1 more source
Frontiers in Public Health, 2021 Background: Mounting evidence has revealed the interrelationship between thyroid and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to explain the thyroid dysfunction and autoimmune thyroid disorders observed after coronavirus disease 2019 (
D. Lui +5 more
semanticscholar +1 more source
The Role of the Microbiota in Graves’ Disease and Graves’ Orbitopathy
Frontiers in Cellular and Infection Microbiology, 2021 Graves‘ disease (GD) is a clinical syndrome with an enlarged and overactive thyroid gland, an accelerated heart rate, Graves’ orbitopathy (GO), and pretibial myxedema (PTM). GO is the most common extrathyroidal complication of GD. GD/GO has a significant
Jueyu Hou +3 more
semanticscholar +1 more source